Cargando…
Short Onset and Enhanced Analgesia Following Nasal Administration of Non-Controlled Drugs in Nanovesicular Systems
Nasal nanovesicular delivery systems (NVS) containing the noncontrolled analgesic drugs Ketoprofen, Butorphanol or Tramadol, incorporated in a phospholipid nanovesicular carrier, were designed and investigated. The systems were first characterized for their physicochemical properties. Due to their c...
Autores principales: | Touitou, Elka, Natsheh, Hiba, Boukeileh, Shatha, Awad, Rania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309003/ https://www.ncbi.nlm.nih.gov/pubmed/34203555 http://dx.doi.org/10.3390/pharmaceutics13070978 |
Ejemplares similares
-
Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment
por: Touitou, Elka, et al.
Publicado: (2018) -
Improved Efficiency of Pomegranate Seed Oil Administrated Nasally
por: Natsheh, Hiba, et al.
Publicado: (2022) -
Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties
por: Natsheh, Hiba, et al.
Publicado: (2020) -
Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions
por: Touitou, Elka, et al.
Publicado: (2021) -
Film Forming Systems for Delivery of Active Molecules into and across the Skin
por: Touitou, Elka, et al.
Publicado: (2023)